EE04768B1 - Esmapakend ja meetod selle valmistamiseks - Google Patents

Esmapakend ja meetod selle valmistamiseks

Info

Publication number
EE04768B1
EE04768B1 EEP200100131A EEP200100131A EE04768B1 EE 04768 B1 EE04768 B1 EE 04768B1 EE P200100131 A EEP200100131 A EE P200100131A EE P200100131 A EEP200100131 A EE P200100131A EE 04768 B1 EE04768 B1 EE 04768B1
Authority
EE
Estonia
Prior art keywords
manufacture
primary packaging
packaging
primary
Prior art date
Application number
EEP200100131A
Other languages
English (en)
Estonian (et)
Inventor
Lundgren Anna
Sundgren Mats
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200100131A publication Critical patent/EE200100131A/xx
Publication of EE04768B1 publication Critical patent/EE04768B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/062—Carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
EEP200100131A 1998-09-01 1999-08-24 Esmapakend ja meetod selle valmistamiseks EE04768B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802938A SE9802938D0 (sv) 1998-09-01 1998-09-01 Improved stability for injection solutions
PCT/SE1999/001440 WO2000012043A1 (en) 1998-09-01 1999-08-24 Improved stability for injection solutions

Publications (2)

Publication Number Publication Date
EE200100131A EE200100131A (et) 2002-06-17
EE04768B1 true EE04768B1 (et) 2007-02-15

Family

ID=20412436

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100131A EE04768B1 (et) 1998-09-01 1999-08-24 Esmapakend ja meetod selle valmistamiseks

Country Status (34)

Country Link
US (4) US6576245B1 (es)
EP (1) EP1109526B1 (es)
JP (1) JP2002523184A (es)
KR (1) KR100614162B1 (es)
CN (1) CN1230141C (es)
AR (1) AR033788A1 (es)
AT (1) ATE262882T1 (es)
AU (1) AU754447C (es)
BR (1) BR9913261A (es)
CA (1) CA2340238C (es)
CZ (1) CZ2001743A3 (es)
DE (1) DE69916082T2 (es)
DK (1) DK1109526T3 (es)
EE (1) EE04768B1 (es)
ES (1) ES2217808T3 (es)
HK (1) HK1035482A1 (es)
HU (1) HUP0104161A3 (es)
ID (1) ID28015A (es)
IL (2) IL141333A0 (es)
IS (1) IS2230B (es)
MY (1) MY120822A (es)
NO (1) NO322292B1 (es)
NZ (1) NZ509985A (es)
PL (1) PL195244B1 (es)
PT (1) PT1109526E (es)
RU (1) RU2224499C2 (es)
SA (1) SA99200573B1 (es)
SE (1) SE9802938D0 (es)
SK (1) SK285474B6 (es)
TR (1) TR200100679T2 (es)
TW (1) TWI228987B (es)
UA (1) UA73282C2 (es)
WO (1) WO2000012043A1 (es)
ZA (1) ZA200101590B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (sv) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US6802828B2 (en) * 2001-11-23 2004-10-12 Duoject Medical Systems, Inc. System for filling and assembling pharmaceutical delivery devices
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
AU2004206842A1 (en) * 2003-01-14 2004-08-05 Teva Pharmaceutical Industries, Ltd. Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
KR100505557B1 (ko) * 2003-02-10 2005-08-03 조을룡 약병마개 제조용 고무 조성물
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
US20070166187A1 (en) * 2006-01-18 2007-07-19 Song Jing F Stabilization of paricalcitol using chlorobutyl or chlorinated butyl stoppers
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
EP2760509B1 (en) * 2011-09-27 2023-04-05 Becton Dickinson France Use of plasma treated silicone oil as a coating in a medical injection device
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4381779A (en) 1981-07-16 1983-05-03 Sterling Drug Inc. Deformable slidable piston to provide self-aspiration in hypodermic cartridge ampoules
EP0390244B1 (en) * 1989-03-28 1993-01-07 Duphar International Research B.V Pre-filled injection device comprising a barrel wherein a liquid diazepam formulation is accomodated
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
SE9501472D0 (sv) * 1995-04-21 1995-04-21 Pharmacia Ab Truncated IGF-I
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
TW541316B (en) 1995-12-21 2003-07-11 Astrazeneca Ab Prodrugs of thrombin inhibitors
SE9601556D0 (sv) * 1996-04-24 1996-04-24 Astra Ab New pharmaceutical formulation of a thrombin inhibitor for parenteral use
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions

Also Published As

Publication number Publication date
SK285474B6 (sk) 2007-02-01
AU754447B2 (en) 2002-11-14
MY120822A (en) 2005-11-30
NO20011032L (no) 2001-04-30
ID28015A (id) 2001-05-03
US20030190310A1 (en) 2003-10-09
SE9802938D0 (sv) 1998-09-01
TR200100679T2 (tr) 2001-07-23
CN1314804A (zh) 2001-09-26
PL346471A1 (en) 2002-02-11
EE200100131A (et) 2002-06-17
DE69916082D1 (de) 2004-05-06
TWI228987B (en) 2005-03-11
IS2230B (is) 2007-04-15
JP2002523184A (ja) 2002-07-30
ES2217808T3 (es) 2004-11-01
US6998136B2 (en) 2006-02-14
SA99200573B1 (ar) 2006-09-20
PL195244B1 (pl) 2007-08-31
RU2224499C2 (ru) 2004-02-27
AU5890399A (en) 2000-03-21
KR20010073070A (ko) 2001-07-31
DK1109526T3 (da) 2004-07-05
KR100614162B1 (ko) 2006-08-25
ZA200101590B (en) 2002-05-27
BR9913261A (pt) 2001-05-22
IL141333A0 (en) 2002-03-10
NZ509985A (en) 2002-12-20
HUP0104161A3 (en) 2002-08-28
DE69916082T2 (de) 2004-10-21
NO322292B1 (no) 2006-09-11
CZ2001743A3 (cs) 2002-01-16
US6660279B2 (en) 2003-12-09
EP1109526A1 (en) 2001-06-27
EP1109526B1 (en) 2004-03-31
US20060233778A1 (en) 2006-10-19
US6576245B1 (en) 2003-06-10
AR033788A1 (es) 2004-01-07
NO20011032D0 (no) 2001-02-28
AU754447C (en) 2006-10-19
ATE262882T1 (de) 2004-04-15
US20040235731A1 (en) 2004-11-25
UA73282C2 (en) 2005-07-15
CA2340238A1 (en) 2000-03-09
WO2000012043A1 (en) 2000-03-09
IL141333A (en) 2006-07-05
HUP0104161A2 (hu) 2002-04-29
HK1035482A1 (en) 2001-11-30
SA99200573A (ar) 2005-12-03
PT1109526E (pt) 2004-07-30
SK2822001A3 (en) 2001-08-06
CA2340238C (en) 2009-01-06
CN1230141C (zh) 2005-12-07
IS5845A (is) 2001-02-15

Similar Documents

Publication Publication Date Title
EE04768B1 (et) Esmapakend ja meetod selle valmistamiseks
EE03676B1 (et) Mullpakend, selle valmistamise meetod ja mullpakendi kasutamine
EE200000047A (et) Elektriline seadis ja selle valmistamise meetod
EE9600194A (et) Isekleepuv mark ja meetod selle valmistamiseks
EE04713B1 (et) Konstruktsiooniline laminaatelement ja selle valmistamismeetod
DK1085981T3 (da) Fremgangsmåde til emballering
EE9900454A (et) Varjestuskest ja varjestuskesta valmistamismeetod
ID27859A (id) Tampon dan metoda pembuatannya
ID27031A (id) Komposisi farmasi bersalut enterik dan metode pembuatannya
FI972037A0 (fi) Parannettu menetelmä syötävien pakkausten valmistamiseksi ja koostumuksia niitä varten
ID26990A (id) Metode pembuatan dimetilnaftalena
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
PT1140824E (pt) Metodo para producao de 3-alcanoilindolos e 3-alquilindolos
DE69939417D1 (de) In-Line Inspektion von Behältern
DE69941874D1 (de) Optielektronisches bauelement und herstellungsverfahren
ID28025A (id) Metode pembuatan aminonitril dan diamina
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
ID17769A (id) Kemasan dan metode pembuatannya
ID22367A (id) Lampu dan metoda pembuatannya
EE200100305A (et) Preparaat, selle kasutamine ja valmistamismeetod
ID19540A (id) Metode pembuatan turunan-turunan benzofenon
EE200000180A (et) Tsentraalne läbiveokanal ja meetod selle rakendamiseks
GB9818723D0 (en) Light tight package and method of forming the same
PT855146E (pt) Processo de fabrico de uma entretela termocolante e entretela termocolante assim obtida
FI981193A (fi) Pakkaussuoja ja menetelmä pakkaussuojan valmistamiseksi

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20100824